Imetelstat
Geron Corporation
['mds']
excellent session by mbbs. zeida at #asco23 about the results of the imerge clinical trial where imetelstat demonstrated highly statistically significant and clinically meaningful benefit compared with pbo in this heavily transfusion dependent lr-mds pts in need of novel therapy 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.